UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 176

Sortiert nach

Tumor Dormancy and Relapse: From a Natural Byproduct of Evolution to a Disease State

Cancer research (Chicago, Ill.), 2017-05, Vol.77 (10), p.2564-2569

Manjili, Masoud H

2017

Link zum Volltext

Verfügbarkeit prüfen

The Adaptation Model of Immunity: Signal IV Matters Most in Determining the Functional Outcomes of Immune Responses

The Journal of immunology (1950), 2023-03, Vol.210 (5), p.521-530

Manjili, Masoud H

2023

Link zum Volltext

Verfügbarkeit prüfen

The premise of personalized immunotherapy for cancer dormancy

Oncogene, 2020-05, Vol.39 (22), p.4323-4330

Manjili, Masoud H

2020

Link zum Volltext

Verfügbarkeit prüfen

The adaptation model of immunity: A new insight into aetiology and treatment of multiple sclerosis

Scandinavian journal of immunology, 2023-04, Vol.97 (4), p.e13255-n/a

Manjili, Masoud H.

2023

Link zum Volltext

Verfügbarkeit prüfen

The adaptation model of immunity: Is the goal of central tolerance to eliminate defective T cells or self‐reactive T cells?

Scandinavian journal of immunology, 2022-10, Vol.96 (4), p.e13209-n/a

Manjili, Masoud H.

2022

Link zum Volltext

Verfügbarkeit prüfen

The inherent premise of immunotherapy for cancer dormancy

Cancer research (Chicago, Ill.), 2014-12, Vol.74 (23), p.6745-6749

Manjili, Masoud H

2014

Link zum Volltext

Verfügbarkeit prüfen

Pattern recognition of tumor dormancy and relapse beyond cell-intrinsic and cell-extrinsic pathways

Seminars in cancer biology, 2022-01, Vol.78, p.1-4

2022

Link zum Volltext

Verfügbarkeit prüfen

Multifaceted functions of chronic inflammation in regulating tumor dormancy and relapse

Seminars in cancer biology, 2022-01, Vol.78, p.17-22

2022

Link zum Volltext

Verfügbarkeit prüfen

From Reductionistic Approach to Systems Immunology Approach for the Understanding of Tumor Microenvironment

International journal of molecular sciences, 2023-07, Vol.24 (15), p.12086

2023

Link zum Volltext

Verfügbarkeit prüfen

The microbiome and breast cancer: a review

Breast cancer research and treatment, 2019-12, Vol.178 (3), p.493-496

2019

Link zum Volltext

Verfügbarkeit prüfen

The quantum model of T‐cell activation: Revisiting immune response theories

Scandinavian journal of immunology, 2024-08, Vol.100 (2), p.e13375-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic cancer vaccines: past, present, and future

Advances in cancer research, 2013, Vol.119, p.421-475

2013

Link zum Volltext

Verfügbarkeit prüfen

The Roles of Autophagy and Senescence in the Tumor Cell Response to Radiation

Radiation research, 2020-08, Vol.194 (2), p.103

2020

Link zum Volltext

Verfügbarkeit prüfen

IFN‐γ orchestrates tumor elimination, tumor dormancy, tumor escape, and progression

Journal of leukocyte biology, 2018-06, Vol.103 (6), p.1219-1223

2018

Link zum Volltext

Verfügbarkeit prüfen

Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer

Cancers, 2019-08, Vol.11 (8), p.1207

2019

Link zum Volltext

Verfügbarkeit prüfen

Human mast cells present antigen to autologous CD4+ T Cells

Journal of allergy and clinical immunology, 2018-01, Vol.141 (1), p.311-321.e10

2018

Link zum Volltext

Verfügbarkeit prüfen

Immune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem Cells

Cancer research (Chicago, Ill.), 2009-04, Vol.69 (7), p.2887-2895

2009

Link zum Volltext

Verfügbarkeit prüfen

Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function

Journal of translational medicine, 2009-10, Vol.7 (1), p.89-89, Article 89

2009

Link zum Volltext

Verfügbarkeit prüfen

Local and distant tumor dormancy during early stage breast cancer are associated with the predominance of infiltrating T effector subsets

Breast cancer research : BCR, 2020-10, Vol.22 (1), p.116-116, Article 116

2020

Link zum Volltext

Verfügbarkeit prüfen

CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome

Human pathology, 2012-03, Vol.43 (3), p.364-373

2012

Link zum Volltext

Verfügbarkeit prüfen

The crosstalking immune cells network creates a collective function beyond the function of each cellular constituent during the progression of hepatocellular carcinoma

Scientific reports, 2023-08, Vol.13 (1), p.12630-12630, Article 12630

2023

Link zum Volltext

Verfügbarkeit prüfen

IFN-γ Rα is a key determinant of CD8+ T cell-mediated tumor elimination or tumor escape and relapse in FVB mouse

PloS one, 2013-12, Vol.8 (12), p.e82544-e82544

2013

Link zum Volltext

Verfügbarkeit prüfen

GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells

Breast cancer research and treatment, 2010-08, Vol.123 (1), p.39-49

2010

Link zum Volltext

Verfügbarkeit prüfen

Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma

Cell reports (Cambridge), 2022-03, Vol.38 (9), p.110454-110454, Article 110454

2022

Link zum Volltext

Verfügbarkeit prüfen

An immunologic portrait of cancer

Journal of translational medicine, 2011-08, Vol.9 (1), p.146-146, Article 146

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 176

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(163)

Publikationsform

Sprache

Englisch
(176)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(113)
Life Sciences & Biomedicine
(109)
Animals
(66)
Humans
(65)
Immunology
(60)
Female
(46)
Mice
(44)
Oncology
(43)
Immunotherapy
(39)
Tumors
(37)
Breast Cancer
(35)
Biological And Medical Sciences
(27)
Medical Sciences
(27)
Cancer
(24)
Cell Line, Tumor
(24)
Neoplasms - Immunology
(20)
Immune System
(18)
Mammary Neoplasms, Experimental - Immunology
(16)
Review
(16)
Antigens
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tumor Dormancy and Relapse: From a Natural Byproduct of Evolution to a Disease State

The Adaptation Model of Immunity: Signal IV Matters Most in Determining the Functional Outcomes of Immune Responses

The premise of personalized immunotherapy for cancer dormancy

The adaptation model of immunity: A new insight into aetiology and treatment of multiple sclerosis

The adaptation model of immunity: Is the goal of central tolerance to eliminate defective T cells or self‐reactive T cells?

The inherent premise of immunotherapy for cancer dormancy

Pattern recognition of tumor dormancy and relapse beyond cell-intrinsic and cell-extrinsic pathways

Multifaceted functions of chronic inflammation in regulating tumor dormancy and relapse

From Reductionistic Approach to Systems Immunology Approach for the Understanding of Tumor Microenvironment

The microbiome and breast cancer: a review

The quantum model of T‐cell activation: Revisiting immune response theories

Therapeutic cancer vaccines: past, present, and future

The Roles of Autophagy and Senescence in the Tumor Cell Response to Radiation

IFN‐γ orchestrates tumor elimination, tumor dormancy, tumor escape, and progression

Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer

Human mast cells present antigen to autologous CD4+ T Cells

Immune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem Cells

Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function

Local and distant tumor dormancy during early stage breast cancer are associated with the predominance of infiltrating T effector subsets

CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome

The crosstalking immune cells network creates a collective function beyond the function of each cellular constituent during the progression of hepatocellular carcinoma

IFN-γ Rα is a key determinant of CD8+ T cell-mediated tumor elimination or tumor escape and relapse in FVB mouse

GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells

Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma

An immunologic portrait of cancer

Suchergebnisse filtern